<?xml version="1.0"?>
<?xml-stylesheet type="text/xsl" href="billres.xsl"?>
<!DOCTYPE bill PUBLIC "-//US Congress//DTDs/bill.dtd//EN" "bill.dtd">
<bill bill-stage="Introduced-in-House" dms-id="HCC397772EFBC415EADCDD038F179F2C7" public-private="public" key="H" bill-type="olc"><metadata xmlns:dc="http://purl.org/dc/elements/1.1/">
<dublinCore>
<dc:title>118 HR 4304 IH: Increase Support for Life-saving Endocrine Transplantation Act</dc:title>
<dc:publisher>U.S. House of Representatives</dc:publisher>
<dc:date>2023-06-22</dc:date>
<dc:format>text/xml</dc:format>
<dc:language>EN</dc:language>
<dc:rights>Pursuant to Title 17 Section 105 of the United States Code, this file is not subject to copyright protection and is in the public domain.</dc:rights>
</dublinCore>
</metadata>
<form>
<distribution-code display="yes">I</distribution-code><congress display="yes">118th CONGRESS</congress><session display="yes">1st Session</session><legis-num display="yes">H. R. 4304</legis-num><current-chamber>IN THE HOUSE OF REPRESENTATIVES</current-chamber><action display="yes"><action-date date="20230622">June 22, 2023</action-date><action-desc><sponsor name-id="R000103">Mr. Rosendale</sponsor> (for himself, <cosponsor name-id="B001298">Mr. Bacon</cosponsor>, and <cosponsor name-id="G000596">Ms. Greene of Georgia</cosponsor>) introduced the following bill; which was referred to the <committee-name committee-id="HIF00">Committee on Energy and Commerce</committee-name></action-desc></action><legis-type>A BILL</legis-type><official-title display="yes">To regulate human cadaveric islets for transplantation as organs.</official-title></form><legis-body id="H22AA8697A2BE4331B0E68BD832CBF6D4" style="OLC"><section id="HFDAD2FB4155B42068096639A13AA0507" section-type="section-one"><enum>1.</enum><header>Short title</header><text display-inline="no-display-inline">This Act may be cited as the <quote><short-title>Increase Support for Life-saving Endocrine Transplantation Act</short-title></quote> or the <quote><short-title>ISLET Act</short-title></quote>.</text></section><section commented="no" display-inline="no-display-inline" id="H259282F5845945A4ADA02E5BB45BD1C3"><enum>2.</enum><header>Regulation of human cadaveric islet transplants</header><subsection commented="no" display-inline="no-display-inline" id="HD5EED33F7FC84095B4C8B73CC960305C"><enum>(a)</enum><header display-inline="yes-display-inline">In general</header><text display-inline="yes-display-inline">Section 374(d)(2) of the Public Health Service Act (<external-xref legal-doc="usc" parsable-cite="usc/42/274b">42 U.S.C. 274b(d)(2)</external-xref>) is amended by striking <quote>pancreas,</quote> and inserting <quote>and pancreas, human cadaveric islets,</quote>.</text></subsection><subsection commented="no" display-inline="no-display-inline" id="HFE40DCA6BD4B4147A748DC1911D73C68"><enum>(b)</enum><header>Clarification</header><text>Notwithstanding any other provision of law, none of the following terms includes human cadaveric islets:</text><paragraph commented="no" display-inline="no-display-inline" id="HA25090E845D74B6CB57D7AA61C343D1D"><enum>(1)</enum><text display-inline="yes-display-inline">The term <term>drug</term>, as defined in section 201(g) of the Federal Food, Drug, and Cosmetic Act (<external-xref legal-doc="usc" parsable-cite="usc/21/321">21 U.S.C. 321(g)</external-xref>).</text></paragraph><paragraph commented="no" display-inline="no-display-inline" id="H1B04368EF9264092BE1B314B0ADA79AA"><enum>(2)</enum><text display-inline="yes-display-inline">The term <term>biological product</term>, as defined in section 351(i) of the Public Health Service Act (<external-xref legal-doc="usc" parsable-cite="usc/42/262">42 U.S.C. 262(i)</external-xref>).</text></paragraph><paragraph commented="no" display-inline="no-display-inline" id="H7F5DD850139B4B49A412FAC2FCC3C7A5"><enum>(3)</enum><text>The term <term>human cells, tissues, or cellular or tissue-based products (HCT/Ps)</term>, as defined in section 1271.3 of title 21, Code of Federal Regulations (or any successor regulations).</text></paragraph></subsection><subsection id="H9A0ED89970E841D9B855D00E20D7661A"><enum>(c)</enum><header>Regulations</header><paragraph commented="no" display-inline="no-display-inline" id="HFB3DAA11544B49EEAFA6B019E951753C"><enum>(1)</enum><header>In general</header><text display-inline="yes-display-inline">Not later than 1 year after the date of enactment of this Act, the Secretary of Health and Human Services (referred to in this section as the <quote>Secretary</quote>) shall update regulations promulgated under parts F, G, and H of title III of the Public Health Service Act (<external-xref legal-doc="usc" parsable-cite="usc/42/262">42 U.S.C. 262 et seq.</external-xref>, 264 et seq., 273 et seq.) and the Federal Food, Drug, and Cosmetic Act (<external-xref legal-doc="usc" parsable-cite="usc/21/301">21 U.S.C. 301 et seq.</external-xref>), and such other regulations as the Secretary determines appropriate, to carry out the amendment made by subsection (a).</text></paragraph><paragraph commented="no" display-inline="no-display-inline" id="H67EEE2FB5D68498A939433AB7BFA3832"><enum>(2)</enum><header>Report</header><text>Not later than 6 months after the date of enactment of this Act, the Secretary shall report to Congress on the progress made in updating regulations as required under paragraph (1).</text></paragraph></subsection></section></legis-body></bill> 

